Proteases, proteasomes and apoptosis: Breaking Ub is hard to do

Cell Death and Differentiation

Volumn 12, Issue 9, 2005, Pages 1213-1217

  Taylor, R C ^a   Adrain, C ^a   Martin, S J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSOME; BH3 PROTEIN; BORTEZOMIB; CASPASE; CASPASE 12; CASPASE 2; CASPASE 8; CASPASE 9; CATHEPSIN; CYSTEINE PROTEINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME; PROTEASOME INHIBITOR; PROTEINASE; UBIQUITIN;

APOPTOSIS; ARTICLE; CANCER; CANCER CELL CULTURE; CELL SURVIVAL; CLINICAL TRIAL; CYTOTOXIC LYMPHOCYTE; CYTOTOXICITY; DRUG SYNTHESIS; DRUG TARGETING; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; HUMAN; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FUNCTION; TUMOR VASCULARIZATION;

ANIMALS; APOPTOSIS; CLINICAL TRIALS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; HUMANS; MODELS, BIOLOGICAL; NECROSIS; NEOPLASMS; NF-KAPPA B; PEPTIDE HYDROLASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; UBIQUITIN;

EID: 23944490171     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401703     Document Type: Article

References (40)

1. Martin SJ and Green DR (1995) Cell 82: 349-352
2. Fischer U et al. (2003) Cell Death Differ. 10: 76-100
3. Darmon AJ et al. (1995) Nature 377: 446-448
4. Fan Z et al. (2003) Cell 112: 659-672
5. Leist M and Jaattela M (2001) Cell Death Differ. 8: 324-326
6. Salvesen GS and Dixit VM (1999) Proc. Natl. Acad. Sci. USA 96: 10964-10967
7. Green DR (1998) Cell 94: 695-698
8. Adrain C and Martin SJ (2001) Trends Biochem. Sci. 26: 390-397
9. Nakagawa T et al. (2000) Nature 403: 98-103
10. Saleh M et al. (2004) Nature 429: 75-79
11. Van de Craen M et al. (1999) Cell Death Differ. 6: 1117-1124
12. Hitomi J et al. (2004) J. Cell Biol. 165: 347-356
13. Ruiz-Vela A et al. (2005) EMBO Rep. 6: 379-385
14. Lassus P et al. (2002) Science 297: 1352-1354
15. Sledz CA et al. (2003) Nat. Cell Biol. 5: 834-839
16. Bergeron L et al. (1998) Genes Dev. 12: 1304-1314
17. Hill MM et al. (2004) EMBO J. 23: 2134-2145
18. Marsden VS et al. (2002) Nature 419: 634-637
19. Wei MC et al. (2001) Science 292: 727-730
20. Wei MC et al. (2000) Genes Dev. 14: 2060-2071
21. Kuwana T et al. (2005) Mol. Cell 17: 525-535
22. Chen L et al. (2005) Mol. Cell 17: 393-403
23. Strasser A (2005) Nat. Rev. Immunol. 5: 189-200
24. Villunger A et al. (2003) Science 302: 1036-1038
25. Bouillet P et al. (1999) Science 286: 1735-1738
26. Lundgren J et al. (2003) Mol. Cell. Biol. 23: 5320-5330
27. Sun XM et al. (2004) Mol. Cell 14: 81-93
28. Adrain C et al. (2004) J. Biol. Chem. 279: 36923-36930
29. Martin SJ (2002) Cell 109: 793-796
30. Ley R et al. (2003) J. Biol. Chem. 278: 18811-18816
31. Akiyama T et al. (2003) EMBO J. 22: 6653-6664
32. Wang CY et al. (1998) Science 281: 1680-1683
33. Van Antwerp DJ et al. (1996) Science 274: 787-789
34. Nikrad M et al. (2005) Mol. Cancer Ther. 4: 443-449
35. Adams J (2004) Nat. Rev. Cancer 4: 349-360
36. Drexler HC (1997) Proc. Natl. Acad. Sci. USA 94: 855-860
37. Fukazawa H et al. (2004) Mol. Cancer Ther. 3: 1281-1288
38. Mitsiades N et al. (2002) Proc. Natl. Acad. Sci. USA 99: 14374-14379
39. Hideshima T et al. (2001) Cancer Res. 61: 3071-3076
40. Cusack Jr JC et al. (2001) Cancer Res. 61: 3535-3540